Thermo Fisher Scientific
The SARS-CoV-2 pandemic has spurred rapid innovation in donor testing and prognostic biomarker reliability. This webcast will describe a comprehensive LC-MS based assay for detecting and quantifying critical proteins from nasopharyngeal swab and plasma samples to confirm RT-PCR test results and assess disease severity.
Group Head, Proteomics Facility, Indian Institute of Technology Bombay, Mumbai Sanjeeva Srivastava, FRSB, FRSC, FRSM, obtained his Ph.D. from University of Alberta, his post-doc from Harvard Medical School and joined Indian Institute of Technology (IIT) Bombay, Mumbai where he is currently a full Professor. His research on protein biomarkers of infectious diseases and brain tumors has resulted in 120+ publications and over 20 patents filed.
* Required field
Don't have an account ?